[EN] GLUCAGON ANTAGONISTS/INVERSE AGONISTS<br/>[FR] ANTAGONISTES/AGONISTES INVERSES DU GLUCAGON
申请人:NOVO NORDISK AS
公开号:WO1999001423A1
公开(公告)日:1999-01-14
Non-peptide compounds comprising a central hydrazide motif and methods for the synthesis thereof. The compounds act to antagonize the action of the glucagon peptide hormone.
Combination of antioxidant substances for the treatment of alzheimer's disease
申请人:Colba R & D Inc.
公开号:US20030158237A1
公开(公告)日:2003-08-21
Disclosed is a pharmaceutical composition for the treatment of cognitive symptoms caused by Alzheimer's disease in a mammal. This composition comprising vitamin E, quercitin, caffeic acid, nicotinic acid or derivatives and/or analog thereof, and a pharmaceutically acceptable excipient.